The downregulation of both proteins occurs during the onset of clinical symptoms in familial Alzheimer's disease, and our analysis found that the downregulation of NPTX2 in CSF corresponds to a downregulation in brain tissue. The gene discussed is NPTX2; the disease is familial Alzheimer disease.